Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. Sattler is active.

Publication


Featured researches published by J. Sattler.


Inflammation Research | 1988

Food-induced histaminosis as an epidemiological problem: plasma histamine elevation and haemodynamic alterations after oral histamine administration and blockade of diamine oxidase (DAO).

J. Sattler; D. Häfner; Klotter Hj; W. Lorenz; P. K. Wagner

In a randomized controlled trial, 30 pigs were orally treated with histamine (60 mg). In addition, half of the animals underwent a specific blockade of the enzyme diamine oxidase (DAO), which is the main histamine catabolising enzyme in the intestinal tract. Only these DAO-blocked animals exhibited severe clinical symptoms (e.g. hypotension, flush, vomiting) and, in parallel, showed tremendous elevations of plasma histamine levels of up to 160 ng/ml. 3 out of 15 animals in this group died within the experimental period. In contrast, the control animals neither exhibited plasma histamine levels above 5 ng/ml nor had any clinical reactions. These results contradict the current opinion that oral histamine intake in food is not clinically relevant, especially since many commonly used drugs are DAO-inhibitors and approximately 20% of our population take these drugs. Apart from drugs, some other factors (alcohol, spoilt food etc.) can also function via a blockade of DAO as an additional risk. DAO-blockade is therefore a real epidemiological problem. Evidence is presented here for the new disease concept: Food-Induced Histaminosis.


Inflammation Research | 1985

Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects?

J. Sattler; R. Hesterberg; W. Lorenz; U. Schmidt; M. Crombach; C. D. Stahlknecht

Three hundred and forty-one drugs, commonly used in intensive care units (ICU), were chosen for an investigation of possible activation or inhibition of the histamine metabolizing enzyme diamine oxidase (DAO). After examination of 164 substances, using both canine and human DAO in anin vitro screening test, 61 agents inhibited DAO activity to various degrees. Of these, 44 inhibited the enzyme from both species, 4 inhibited the canine enzyme only and 13 the human DAO only. No. compound tested was able to enhance the enzyme activity.The inhibiting agents included representatives of all major therapeutic groups. A particlarly strong inhibition was observed with the neuromuscular blocking drugsd-tubocurarine, pancuronium and alcuronium, however, the other commonly used neuromuscular blocking drug, suxamethonium, was without effect. Similarly with the cephalosporines, cefotiame and cefuroxime caused a marked inhibition of the human DAO activity, whereas another regularly-used substance of this class, cefotaxime, inhibited neither the human nor the canine enzyme in concentrations up to 10−3M. The observation that within a given therapeutic group some members inhibit and others do not, could be useful in choosing a therapy concept which minimizes the risk of a more severe ‘histamine’ reaction in seriously ill patients.


Inflammation Research | 1984

Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: Fact or fictions?

R. Hesterberg; J. Sattler; W. Lorenz; C. D. Stahlknecht; H. Barth; M. Crombach; D. Weber

To understand the role of histamine in the aetiology and pathogenesis of human diseases reliable data are urgently needed for the histamine content and for the activities of histamine-forming and-inactivating enzymes in human tissues. In order to make a substantial progress toward this aim a tissue-sampling programme during surgical interventions was carefully conceived and conducted. From March 1982 until January 1983 106 tissue specimens were taken from 56 patients who underwent surgery. Only healthy tissues, not injured or oedematous, and without adherent structures were taken by only one surgeon who was interested in this research and experienced in tissue preparation procedures in biochemistry. The times of ‘warm’ ischaemia during the operative procedures were visually estimated, the times between resection of the organs or specimens and deep-freezing of the tissues were precisely recorded.Compared to previous work in the literature and especially to our own work using the same assays for determination higher histamine contents were found in this study in most of the tissues, in particular in the gastrointestinal tract. Also the diamine oxidase activities were considerably higher in many organs, e.g. 3–4 times higher in the gastrointestinal tract when compared with those in publications of our group who used always the same analytical test. However, the histamine methyltransferase activities in this study were not at variance to those determined in previous investigations. Many of them were reported in this communication for the first time.Since the methods for histamine determination and those for measuring enzymic activities were not different in this study and in previous communications of our group we are convinced that the optimized tissue-sampling and-preparation techniques were responsible for the higher values in this communication. But the problem of the ‘warm’ ischaemia period could not be solved by sample-taking procedures of this type during operations. There are good reasons to prefer biopsy specimens for the analysis of histamine storage and metabolism in human tissues in health and disease, but — unfortunately — they are not always available.


Inflammation Research | 1990

Human intestinal diamine oxidase (DAO) activity in Crohn's disease: A new marker for disease assessment?

W. U. Schmidt; J. Sattler; R. Hesterberg; H. D. Röher; Th. Zoedler; H. Sitter; W. Lorenz

AbstractThe key-enzyme for the metabolism of diamines in man is diamine oxidase (DAO). Its highest activities are in the intestinal mucosa, localized in the cytoplasm of the mature enterocytes of the small and large bowel. If the gut is affected by inflammation in Crohns disease macroscopical changes are observed. This prospective study investigated if these mucosal alterations are also reflected in changes of mucosal diamine oxidase activity and/or mucosal histamine content respectively. Twenty patients (12 female, 8 male; age:


Inflammation Research | 1989

Food-induced histaminosis under diamine oxidase (DAO) blockade in pigs: Further evidence of the key role of elevated plasma histamine levels as demonstrated by successful prophylaxis with antihistamines

J. Sattler; W. Lorenz; K. Kubo; A. Schmal; S. Sauer; L. Lüben


Inflammation Research | 1991

Elevated plasma histamine concentration as a sensitive real-time parameter for distinct phases of surgical trauma: A tool for technology assessment

H. Sitter; W. Lorenz; Klotter Hj; Dan G. Duda; G. Buess; J. Sattler

\tilde x = 31


Inflammation Research | 1987

Inhibition of intestinal diamine oxidase by detergents: a problem for drug formulations with water insoluble agents applied by the intravenous route?

J. Sattler; R. Hesterberg; U. Schmidt; M. Crombach; W. Lorenz


Archive | 1991

Biochemische Aspekte der Lebersegmentresektion

Klotter Hj; W. Lorenz; H. Sitter; J. Sattler; R. Schindler; A. Gressner; M. Rothmund

, range 18 49 years) undergoing gut resection because of complications in Crohns disease (Jan.–Dec. 1988) formed the basis of the study. Tissue samples of the resected material from areas inflamed and histologically not involved in the disease were investigated for diamine oxidase activities and histamine content. Diamine oxidase activities in the mucosa obtained from the macroscopically normal proximal (155.6; (76–393) mU/g (


Archive | 1987

Ein neues hämorrhagisches Schockmodell am Schwein für die obere gastrointestinale Blutung: Effekt einer Blockade des histaminabbauenden Enzyms Diaminoxydase (DAO)

R. Hesterberg; J. Sattler; W. Lorenz; E. Schmidt; B. Kapp; H.-D. Röher


Archive | 1990

Enterale Aminresorption durch typische Medikamente der chirurgischen Intensivtherapie: Ursache für kardiovasculäre Entgleisungen bei Risikopatienten?

J. Sattler; R. Lindlar; W. Woyke; E. Schmidt; W. Lorenz

\tilde x

Collaboration


Dive into the J. Sattler's collaboration.

Top Co-Authors

Avatar

W. Lorenz

University of Marburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H. Sitter

University of Marburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge